These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27718015)

  • 1. Steroid-responsive hyperammonemic encephalopathy as first manifestation of multiple myeloma.
    Gaiani A; Pompanin S; Zambello R; Briani C; Cagnin A
    Neurol Sci; 2017 Mar; 38(3):503-505. PubMed ID: 27718015
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple myeloma presenting as hyperammonemic encephalopathy.
    Bénet B; Alexandra JF; Andrieu V; Sedel F; Ajzenberg N; Papo T
    J Am Geriatr Soc; 2010 Aug; 58(8):1620-2. PubMed ID: 20942894
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperammonemic encephalopathy as the presenting feature of multiple myeloma].
    Fernández-Álvarez R; González-García E; Fernández-Álvarez C
    Med Clin (Barc); 2016 Nov; 147(10):472-473. PubMed ID: 27567337
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma].
    Issa N; Blondeau B; Dimicoli-Salazar S; Marit G; Morlat P; Camou F
    Rev Med Interne; 2016 Aug; 37(8):567-9. PubMed ID: 26681106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive Plasmablastic Myeloma With Extramedullary Cord Compression and Hyperammonemic Encephalopathy: Case Report and Literature Review.
    Dah K; Lavezo JL; Dihowm F
    Anticancer Res; 2021 Nov; 41(11):5839-5845. PubMed ID: 34732460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Uncommon Case of Hyperammonemic Encephalopathy.
    Frazzini V; Capasso M; Onofrj M
    Neurocrit Care; 2019 Oct; 31(2):439-442. PubMed ID: 31025186
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality.
    Pham A; Reagan JL; Castillo JJ
    Leuk Res; 2013 Oct; 37(10):1229-32. PubMed ID: 23932549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI findings in acute hyperammonemic encephalopathy resulting from decompensated chronic liver disease.
    Sureka J; Jakkani RK; Panwar S
    Acta Neurol Belg; 2012 Jun; 112(2):221-3. PubMed ID: 22426669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urea-splitting urinary tract infection contributing to hyperammonemic encephalopathy.
    Albersen M; Joniau S; Van Poppel H; Cuyle PJ; Knockaert DC; Meersseman W
    Nat Clin Pract Urol; 2007 Aug; 4(8):455-8. PubMed ID: 17673917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative Electroconvulsive Therapy-Associated Severe Hyperammonemic Encephalopathy: A Case Report.
    Hsiao MH; Yeh TC; Ku SC; Tseng YT; Liang CS
    Am J Ther; 2019; 26(6):e784-e786. PubMed ID: 30829663
    [No Abstract]   [Full Text] [Related]  

  • 11. A rare case of hyperammonaemic encephalopathy.
    Pang YJ; Day S; Sumner D; Adegoke K
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31270084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rapid improvement of hyperammonemic encephalopathy by bortezomib treatment in IgD-type multiple myeloma].
    Esaki M; Ishii K; Azuma Y; Tsubokura Y; Yoshimura H; Hotta M; Nakanishi T; Fujita S; Nakaya A; Satake A; Ito T; Nomura S
    Rinsho Ketsueki; 2016 Jul; 57(7):854-8. PubMed ID: 27498728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperammonemic encephalopathy in multiple myeloma.
    Kwan L; Wang C; Levitt L
    N Engl J Med; 2002 May; 346(21):1674-5. PubMed ID: 12024007
    [No Abstract]   [Full Text] [Related]  

  • 14. Unexplained encephalopathy with phenytoin toxicity - hyperammonemia, the underlying cause.
    Pandey S; Sharma PK; Garg RK; Takalkar K
    Neurol India; 2018; 66(6):1829-1831. PubMed ID: 30504595
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperammonemic coma presenting as Hashimoto's encephalopathy.
    Adatia S; Poladia B; Joshi SR; Panikar V; Chauhan V; Hastak SM
    J Assoc Physicians India; 2008 Dec; 56():989-91. PubMed ID: 19322981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperammonemic encephalopathy after adjunction of phenobarbital to chronic topiramate and oxcarbazepine therapy.
    Hantson P; Frederick A; van Rijckevorsel K
    Acta Neurol Belg; 2015 Dec; 115(4):777-8. PubMed ID: 25987415
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of hyperammonemic encephalopathy in patients with multiple myeloma may be associated with the appearance of peripheral blood myeloma cells.
    Ikewaki J; Ogata M; Imamura T; Kohno K; Nakayama T; Kadota J
    Leuk Lymphoma; 2009 Apr; 50(4):667-9. PubMed ID: 19373670
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe hyperammonemia in chimeric antigen receptor T cells recipient-unusual differential diagnosis of encephalopathy syndrome.
    Sumransub N; He F; Weisdorf D; Billington CJ; Aggarwal A; Miller B; Bachanova V
    Bone Marrow Transplant; 2022 Feb; 57(2):286-288. PubMed ID: 34718345
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-Oxoprolinuria in hyperammonemic encephalopathy: Coincidence or worsening factor?
    Rousseau G; Signolet I; Denis MC; Chao de la Barca JM; Mahieu R; Letournel F; Reynier P; Simard G
    Clin Biochem; 2017 Dec; 50(18):1115-1117. PubMed ID: 28974423
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid initial response of myeloma hyperammonemic encephalopathy to L-ornithine-L-aspartate and dexamethasone therapy.
    Patel A; Waheed U; Brett SJ; Rahemtulla A; Apperley JF; Patel PB
    Leuk Lymphoma; 2014 Jan; 55(1):198-200. PubMed ID: 23573827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.